• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

DrFirst Launches CURES 2.0 Integration Through MEDITECH EHR

by Fred Pennic 02/07/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Opioid Prescriptions_Prescribed Medication Costs

Today, DrFirst unveiled its new integrated solution which enables easy access via MEDITECH EHR to California state databases to red-flag opioid ‘doctor shopping’ and reduce overall drug abuse. This newest initiative in DrFirst’s long-time fight to end the opioid epidemic is point-of-care technology that seamlessly connects MEDITECH’s EHR system and California’s prescription drug monitoring program (PDMP).

Importance of CURES 2.0 integration

This new CURES 2.0 integration is critical because it gives clinicians streamlined, real-time access to essential opioid prescription information for individual patients at the point-of-care. Prescribers using DrFirst’s e-prescribing tools within the MEDITECH EHR can quickly check the CURES 2.0 database to view their patients’ opioid prescription history, allowing them to quickly identify patients who may have substance abuse disorders and are “doctor shopping” for prescriptions of controlled substances.

The CURES 2.0 database includes prescriptions of Schedule II, III and IV controlled substances dispensed in California. As of October 2, 2018, with specified exceptions, health care practitioners authorized to prescribe, order, administer, or furnish a controlled substance were required by California law to consult the CURES database. Practitioners must review a patient’s controlled substance history before prescribing Schedule II, III and IV drugs to a patient for the first time, and at least once every four months after that if the substance remains part of the treatment of the patient. In 2016, over 2,000 individuals died from opioid-related overdoses in California and more than 42,000 across the country.

Prescribers do not need to log into CURES 2.0 from a separate browser because patient queries are initiated from within the e-prescribing workflow. Prescription records are returned directly within the EHR automatically once physician credentials are validated in the state’s PDMP.

DrFirst and MEDITECH are the first vendors to offer acute care providers and providers across the continuum access to CURES 2.0 from within e-prescribing workflows. The integration is critical because it gives clinicians streamlined, real-time access to essential opioid prescription information for patients at the point of care. Prescribers can quickly check the CURES 2.0 database to view patients’ opioid prescribing histories, allowing them to easily identify patients who may have substance abuse disorders and are “doctor shopping” for prescriptions of controlled substances.

“Physicians want to do what’s best for their patients and, as technology providers, we have the privilege of helping them deliver care more safely and efficiently,” said Howard Messing, President, and CEO of MEDITECH. “We are confident that, by giving physicians ready-access to in-depth details of patients’ past prescriptions through the integration between MEDITECH and the CURES 2.0 PDMP, physicians will be able to make a meaningful difference in addressing California’s opioid crisis.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: CURES 2.0, DrFirst Interoperability, EPCS, MEDITECH, Opioid Epidemic, Opioid Prescriptions, Prescription drug monitoring programs (PDMPs)

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |